The most interesting is the single patient that had no prior doxorubicin treatment had their heart recover!
Given the patients that had been given doxorubicin would be expected to have significant declines in cardiac output over time (the doses they were given is very high by modern standards) then even holding the decline flat or slightly down could be an amazing regenerative outcome.
What this data does prove is you can give lots of Zantrene to patients without issue. No patient given 7g of doxorubicin would survive.
Ann: Breakthrough Zantrene Heart Protection Discovery, page-306
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9998 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |